Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 661-670 of 9365

Page
per page
  1. ARRY-380
    A8366 ARRY-380
    Target: HER2
    Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor
      ≥28.5 mg/mL
  2. AST-1306
    A8367 AST-1306
    Summary: EGFR/HER2 inhibitor
      ≥22.45 mg/mL
  3. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs antagonist
      ≥34.74 mg/mL
  4. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL
  5. AZ 628
    A8371 AZ 628
    Summary: Raf kinases,potent and ATP-competitive
      ≥22.6 mg/mL
  6. AZ3146
    A8372 AZ3146
    Summary: Mps1 inhibitor,potent and selective
  7. AZD2014
    A8373 AZD2014
    Summary: Novel mTOR inhibitor
      ≥23.15 mg/mL
  8. AZD8330
    A8374 AZD8330
    Target: MEK
    Summary: MEK 1/2 inhibitor
      ≥23.05 mg/mL
  9. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL
  10. Bephenium Hydroxynaphthoate
    A8376 Bephenium Hydroxynaphthoate
    Summary: Anthelmintic agent
      insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL

Items 661-670 of 9365

Page
per page